Elexacaftor-tezacaftor-ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis.
Int Forum Allergy Rhinol.
2024 May;14(5):928-938. doi: 10.1002/alr.23288. Epub 2023 Oct 14. PubMed PMID:
37837613; PubMed Central PMCID:
PMC11131353.
Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis.
J Cyst Fibros.
2023 Sep;22(5):796-803. doi: 10.1016/j.jcf.2023.03.020. Epub 2023 Apr 5. PubMed PMID:
37029015.
Feasibility of free-breathing (19) F MRI image acquisition to characterize ventilation defects in CF and healthy volunteers at wash-in.
Magn Reson Med.
2023 Jul;90(1):79-89. doi: 10.1002/mrm.29630. Epub 2023 Mar 13. PubMed PMID:
36912481; PubMed Central PMCID:
PMC10149612.
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele.
Am J Respir Crit Care Med.
2023 Jul 1;208(1):59-67. doi: 10.1164/rccm.202301-0084OC. PubMed PMID:
36921081; PubMed Central PMCID:
PMC10870849.
Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor.
J Cyst Fibros.
2023 Jan;22(1):119-123. doi: 10.1016/j.jcf.2022.08.018. Epub 2022 Sep 14. PubMed PMID:
36114142.
Dynamic Perfluorinated Gas MRI Shows Improved Lung Ventilation in People with Cystic Fibrosis after Elexacaftor/Tezacaftor/Ivacaftor: An Observational Study.
J Clin Med.
2022 Oct 19;11(20). doi: 10.3390/jcm11206160. PubMed PMID:
36294480; PubMed Central PMCID:
PMC9604637.
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis.
J Cyst Fibros.
2022 Sep;21(5):792-799. doi: 10.1016/j.jcf.2022.03.002. Epub 2022 Mar 14. PubMed PMID:
35300931; PubMed Central PMCID:
PMC9470769.
CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor.
JCI Insight.
2022 Mar 22;7(6). doi: 10.1172/jci.insight.148841. PubMed PMID:
35315358; PubMed Central PMCID:
PMC8986068.
Olfaction before and after initiation of elexacaftor-tezacaftor-ivacaftor in a cystic fibrosis cohort.
Int Forum Allergy Rhinol.
2022 Feb;12(2):223-226. doi: 10.1002/alr.22891. Epub 2021 Oct 28. PubMed PMID:
34709729; PubMed Central PMCID:
PMC8792160.
Acute ST-elevation myocardial infarction in two young women with cystic fibrosis and cystic fibrosis-related diabetes.
J Cyst Fibros.
2022 Jan;21(1):e44-e47. doi: 10.1016/j.jcf.2021.11.013. Epub 2021 Dec 12. PubMed PMID:
34911664.
Foretelling Early Lung Disease Progression in Cystic Fibrosis: The Combined Benefits of Magnetic Resonance Imaging and Newborn Screening.
Am J Respir Crit Care Med.
2021 Oct 15;204(8):880-881. doi: 10.1164/rccm.202107-1727ED. PubMed PMID:
34384036; PubMed Central PMCID:
PMC8534612.
Development of an Advance Care Planning Protocol in a Cystic Fibrosis Outpatient Clinic.
J Palliat Med.
2021 Sep;24(9):1383-1386. doi: 10.1089/jpm.2021.0186. Epub 2021 Jun 30. PubMed PMID:
34191614.
Comparison of single breath hyperpolarized (129) Xe MRI with dynamic (19) F MRI in cystic fibrosis lung disease.
Magn Reson Med.
2021 Feb;85(2):1028-1038. doi: 10.1002/mrm.28457. Epub 2020 Aug 8. PubMed PMID:
32770779; PubMed Central PMCID:
PMC7689687.
Novel imaging techniques for cystic fibrosis lung disease.
Pediatr Pulmonol.
2021 Feb;56 Suppl 1(Suppl 1):S40-S54. doi: 10.1002/ppul.24931. Review. PubMed PMID:
32592531; PubMed Central PMCID:
PMC7808406.
The specialist as primary care provider in CF.
J Cyst Fibros.
2020 Sep;19(5):844-845. doi: 10.1016/j.jcf.2020.03.018. Epub 2020 Apr 22. PubMed PMID:
32335024.
Dynamic perfluorinated gas MRI reveals abnormal ventilation despite normal FEV1 in cystic fibrosis.
JCI Insight.
2020 Jan 30;5(2). doi: 10.1172/jci.insight.133400. PubMed PMID:
31855577; PubMed Central PMCID:
PMC7098716.
Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use.
Pediatr Pulmonol.
2019 Aug;54(8):E16-E18. doi: 10.1002/ppul.24353. Epub 2019 May 7. PubMed PMID:
31066218.
Initial clinical evaluation of stationary digital chest tomosynthesis in adult patients with cystic fibrosis.
Eur Radiol.
2019 Apr;29(4):1665-1673. doi: 10.1007/s00330-018-5703-9. Epub 2018 Sep 25. PubMed PMID:
30255248; PubMed Central PMCID:
PMC6896210.
Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.
J Cyst Fibros.
2018 Nov;17(6):e48-e50. doi: 10.1016/j.jcf.2018.08.003. Epub 2018 Aug 28. PubMed PMID:
30170755.
The in vitro effect of nebulised hypertonic saline on human bronchial epithelium.
Eur Respir J.
2018 May;51(5). doi: 10.1183/13993003.02652-2017. Print 2018 May. PubMed PMID:
29599187; PubMed Central PMCID:
PMC6000726.
Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor: Case Series.
J Pediatr Gastroenterol Nutr.
2018 Mar;66(3):451-454. doi: 10.1097/MPG.0000000000001788. PubMed PMID:
29045347.
Visualizing Ventilation: Application of 19F MRI to CF Lung Disease.
Pediatric pulmonology. Supplement. 2018; 53:207.
Overcoming barriers to a successful transition from pediatric to adult care.
Pediatr Pulmonol.
2017 Nov;52(S48):S52-S60. doi: 10.1002/ppul.23778. Epub 2017 Sep 26. Review. PubMed PMID:
28950427.
Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
Pediatr Pulmonol.
2017 Sep;52(9):1142-1149. doi: 10.1002/ppul.23749. Epub 2017 Jul 24. PubMed PMID:
28737262; PubMed Central PMCID:
PMC5561478.
Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis.
J Cyst Fibros.
2017 Jul;16(4):525-527. doi: 10.1016/j.jcf.2017.05.008. Epub 2017 Jun 8. PubMed PMID:
28602538.
Improving complex medical care while awaiting next-generation CFTR potentiators and correctors: The current pipeline of therapeutics.
Pediatr Pulmonol.
2015 Oct;50 Suppl 40:S66-73. doi: 10.1002/ppul.23253. Review. PubMed PMID:
26335956.
A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy.
Am J Physiol Lung Cell Mol Physiol.
2015 Jan 1;308(1):L33-47. doi: 10.1152/ajplung.00217.2014. Epub 2014 Oct 24. PubMed PMID:
25344067; PubMed Central PMCID:
PMC4281696.
Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers.
Respir Med.
2014 Aug;108(8):1069-74. doi: 10.1016/j.rmed.2014.06.004. Epub 2014 Jun 25. Review. PubMed PMID:
25012949.
Challenges and limitations of testing efficacy of aerosol device delivery in young children.
J Aerosol Med Pulm Drug Deliv.
2014 Aug;27(4):264-71. doi: 10.1089/jamp.2013.1097. Epub 2014 Jan 29. Review. PubMed PMID:
24476048.
Hypertonic saline for cystic fibrosis: worth its salt?.
Expert Rev Respir Med.
2014 Jun;8(3):267-9. doi: 10.1586/17476348.2014.896203. Epub 2014 Mar 26. PubMed PMID:
24666113.
Eosinophilic esophagitis in cystic fibrosis: a case series and review of the literature.
J Cyst Fibros.
2013 Jan;12(1):9-14. doi: 10.1016/j.jcf.2012.09.002. Epub 2012 Oct 22. Review. PubMed PMID:
23085252; PubMed Central PMCID:
PMC3519943.
Osmolytes and ion transport modulators: new strategies for airway surface rehydration.
Curr Opin Pharmacol.
2010 Jun;10(3):294-9. doi: 10.1016/j.coph.2010.04.003. Epub 2010 May 1. Review. PubMed PMID:
20439165; PubMed Central PMCID:
PMC8855330.
Intrapleural hemorrhage after administration of tPA: a case report and review of the literature.
Ther Adv Respir Dis.
2009 Dec;3(6):295-300. doi: 10.1177/1753465809350748. Review. PubMed PMID:
19934281.
Agenesis of the gallbladder.
Clin Gastroenterol Hepatol.
2008 May;6(5):A28. doi: 10.1016/j.cgh.2007.12.050. Epub 2008 Mar 5. PubMed PMID:
18325844.
CF Cells do not Hyperabsorb Sodium in the Setting of Nebulized Hypertonic Saline.
The North American Cystic Fibrosis Conference; 2012 October 11; Orlando, FL, USA. Pediatric Pulmonology Supp, 2012, abstract #105; c00.
Evaluation of CF Lung Disease by MR: A Radiation Free Alternative.
North American Cystic Fibrosis Conference; 2014 October 9; Atlanta, GA, USA. Pediatric Pulmonology Supp 38. 2014, abstract #228; c00.
Women’s Health Concerns Following Lung Transplant.
North American Cystic Fibrosis Conference; 2011; Anaheim, CA, USA. Ped Pulm Supp 34, 2011. Abstract #412; c00.
An In Vitro Study of the Kinetics of Hypertonic Saline on ASL Height.
North American Cystic Fibrosis Conference; 2010 October 21; Baltimore, MD, USA. Pediatric Pulmonology Supp 33, 2010. Abstract#205; c00.
Nebulized Hypertonic Saline Yields Disparate ASL Heights with Sequential Doses.
North American Cystic Fibrosis Conference; 2013 October 11; Salt Lake City, UT, USA. Pediatric Pulmonology Supp 36. 2013, abstract #107; c00.
. Mucus Concentration Affects HBE Response to Nebulized Hypetonic Saline.
North American Cystic Fibrosis Conference; 2014 October 9; Atlanta, GA, USA. Pediatric Pulmonology Supp 38, 2014, abstract #182; c00.
Nebulized Hypertonic Saline Causes Reversible Ciliostasis in Airway Epithelial Cells.
North American Cystic Fibrosis Conference; 2010 October 21; Baltimore, MD, USA. . Pediatric Pulmonology Supp 33, 2010. Abstract#102; c00.
What would you like to do?